Mechanism of Action of Apixaban
Introduction Apixaban is a direct oral anticoagulant (DOAC) used to prevent and treat thrombosis. It is specifically indicated … Read more
moa blog
Mechanism of Action of Empagliflozin
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose … Read more
Mechanism of Action of GLP-1 Receptor Agonists
Introduction GLP-1 receptor agonists are a class of antidiabetic drugs that mimic the action of glucagon-like peptide-1 (GLP-1), … Read more
Mechanism of Action of Carbidopa–Levodopa
Introduction Carbidopa–Levodopa is a cornerstone therapy in the management of Parkinson’s disease. Levodopa serves as a precursor to … Read more
Mechanism of Action of GLP-1 (Glucagon-Like Peptide-1)
Introduction Glucagon-like peptide-1 (GLP-1) is an endogenous incretin hormone secreted from the L-cells of the distal ileum and … Read more
Mechanism of Action of Midodrine
Introduction Midodrine is a prodrug used in the treatment of symptomatic orthostatic hypotension. It works by increasing vascular … Read more
Mechanism of Action of Vedolizumab (Entyvio)
Introduction Vedolizumab is a humanized IgG1 monoclonal antibody used for the treatment of moderate to severe ulcerative colitis … Read more
Mechanism of Action of Aripiprazole (Abilify)
Introduction Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, major depressive disorder (as adjunct), irritability … Read more
Mechanism of Action of Infliximab (Remicade)
Introduction Infliximab is a chimeric (murine-human) IgG1 monoclonal antibody that targets tumor necrosis factor‑α (TNF‑α). It is used … Read more
Mechanism of Action of Dapagliflozin
Introduction Dapagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor, used to treat type 2 diabetes mellitus (T2DM). … Read more